-
Signature
-
/s/ John Faurescu, attorney-in-fact for Dr. Malik
-
Issuer symbol
-
CYTK
-
Transactions as of
-
03 May 2023
-
Net transactions value
-
-$224,280
-
Form type
-
4
-
Filing time
-
03 May 2023, 16:46:54 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CYTK |
Common Stock |
Options Exercise |
$55,720 |
+7,000 |
+4.2% |
$7.96* |
174,183 |
03 May 2023 |
Direct |
F1 |
| transaction |
CYTK |
Common Stock |
Sale |
$280,000 |
-7,000 |
-4% |
$40.00 |
167,183 |
03 May 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-7,000 |
-8.6% |
$0.000000 |
74,322 |
03 May 2023 |
Common Stock |
7,000 |
$7.96 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: